Czech National Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Czech National Bank's BMY Position: Q2 2026 in Review
Czech National Bank increased its Bristol-Myers Squibb (BMY) stake by 4.8% in Q2 2026, buying an estimated $1.53M and bringing the position to 581,252 shares worth $33.5M. The position accounts for 0.18% of the portfolio, ranked #99.
Czech National Bank first reported a position in BMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $33.6M in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Czech National Bank held 581,252 shares of Bristol-Myers Squibb worth $33.5M as of Q2 2026.
- Czech National Bank bought 26,627 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.53M.
- Bristol-Myers Squibb made up 0.18% of Czech National Bank's portfolio in Q2 2026, its #99 holding.
- Czech National Bank first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 16 quarters since.
- Czech National Bank's Bristol-Myers Squibb position peaked at $33.6M in Q1 2026.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.